氨丁卡前列素用于治疗宫缩乏力所致的产后出血有效性分析  

Analysis of the effectiveness of Xinmupei(aminobutaprost) in the treatment of postpartum hemorrhage caused by uterine atony

作　　者：普玲玉 宋正奎 Pu Lingyu;Song Zhengkui(The First People's Hospital of Zhaotong,Zhaotong City,Yunnan Province,Yunnan Zhaotong 657000)

机构地区：[1]云南省昭通市昭通市第一人民医院

出　　处：《中国社区医师》2020年第1期65-66,共2页Chinese Community Doctors

摘　　要：目的:分析氨丁卡前列素(欣母沛)用于治疗宫缩乏力所致产后出血的有效性。方法:2017年8月-2018年7月收治宫缩乏力导致产后出血患者84例,随机分为两组,各42例。对照组给予常规治疗,治疗组给予欣母沛治疗。比较两组治疗效果。结果:治疗组总有效率高于对照组,治疗组产后2 h、24 h出血量均低于对照组,差异均有统计学意义(P<0.05)。结论:对宫缩乏力导致产后出血患者采用欣母沛治疗,整体效果明显。Objective:To analyze the efficacy of Xinmupei(aminobutaprost)in the treatment of postpartum hemorrhage caused by uterine atony.Methods:84 cases of postpartum hemorrhage caused by uterine atony were selected from August 2017 to July 2018,they were randomly divided into the two groups with 42 cases in each group.The control group was given routine treatment and the treatment group was given xinmupei treatment.The therapeutic effects of the two groups were compared.Results:The total effective rate of the treatment group was higher than that of the control group,and the bleeding volume of the treatment group was lower than that of the control group at 2 and 24 hours after delivery,the differences were statistically significant(P<0.05).Conclusion:Xinmupei is effective in the treatment of postpartum hemorrhage caused by uterine atony.

关 键 词：欣母沛 宫缩乏力 产后出血 

分 类 号：R714.461[医药卫生—妇产科学]